Literature DB >> 30578318

On the mechanisms of conjugate vaccines.

Rino Rappuoli1,2, Ennio De Gregorio3, Paolo Costantino4.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30578318      PMCID： PMC6320500          DOI： 10.1073/pnas.1819612116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  13 in total

1.  A sweet T cell response.

Authors:  Rino Rappuoli; Ennio De Gregorio
Journal:  Nat Med       Date:  2011-12-06       Impact factor: 53.440

Review 2.  Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers.

Authors:  Shawn A N Gilchrist; Angeline Nanni; Orin Levine
Journal:  Am J Public Health       Date:  2012-02-16       Impact factor: 9.308

Review 3.  Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.

Authors:  Michael E Pichichero
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

Review 4.  Glycoconjugate vaccines: Principles and mechanisms.

Authors:  Rino Rappuoli
Journal:  Sci Transl Med       Date:  2018-08-29       Impact factor: 17.956

5.  Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C.

Authors:  P Costantino; S Viti; A Podda; M A Velmonte; L Nencioni; R Rappuoli
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

6.  Production of glycoprotein vaccines in Escherichia coli.

Authors:  Julian Ihssen; Michael Kowarik; Sandro Dilettoso; Cyril Tanner; Michael Wacker; Linda Thöny-Meyer
Journal:  Microb Cell Fact       Date:  2010-08-11       Impact factor: 5.328

7.  CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : I. THE SYNTHESIS OFp-AMINOPHENOL beta-GLUCOSIDE, p-AMINOPHENOL beta-GALACTOSIDE, AND THEIR COUPLING WITH SERUM GLOBULIN.

Authors:  W F Goebel; O T Avery
Journal:  J Exp Med       Date:  1929-09-30       Impact factor: 14.307

Review 8.  The new pneumococcal vaccine.

Authors:  S K Obaro
Journal:  Clin Microbiol Infect       Date:  2002-10       Impact factor: 8.067

9.  T Cell-Mediated Humoral Immune Responses to Type 3 Capsular Polysaccharide of Streptococcus pneumoniae.

Authors:  Dustin R Middleton; Lina Sun; Amy V Paschall; Fikri Y Avci
Journal:  J Immunol       Date:  2017-05-31       Impact factor: 5.422

10.  Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.

Authors:  Celina Jin; Malick M Gibani; Maria Moore; Helene B Juel; Elizabeth Jones; James Meiring; Victoria Harris; Jonathan Gardner; Anna Nebykova; Simon A Kerridge; Jennifer Hill; Helena Thomaides-Brears; Christoph J Blohmke; Ly-Mee Yu; Brian Angus; Andrew J Pollard
Journal:  Lancet       Date:  2017-09-28       Impact factor: 79.321
View more
  30 in total

Review 1.  Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli.

Authors:  Christian M Harding; Mario F Feldman
Journal:  Glycobiology       Date:  2019-07-01       Impact factor: 4.313

2.  Isolation and characterization of new human carrier peptides from two important vaccine immunogens.

Authors:  Paeton L Wantuch; Lina Sun; Rachel K LoPilato; Jarrod J Mousa; Robert S Haltiwanger; Fikri Y Avci
Journal:  Vaccine       Date:  2020-01-28       Impact factor: 3.641

3.  Vaccination with a bacterial peptide conjugated to SARS-CoV-2 receptor-binding domain accelerates immunity and protects against COVID-19.

Authors:  Athanasios Blanas; Haiko Karsjens; Aafke de Ligt; Elisabeth J M Huijbers; Karlijn van Loon; Stepan S Denisov; Canan Durukan; Diederik J M Engbersen; Jan Groen; Sven Hennig; Tilman M Hackeng; Judy R van Beijnum; Arjan W Griffioen
Journal:  iScience       Date:  2022-07-05

Review 4.  Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria.

Authors:  Anke Osterloh
Journal:  Vaccines (Basel)       Date:  2022-05-10

5.  Techniques for Developing and Assessing Immune Responses Induced by Synthetic DNA Vaccines for Emerging Infectious Diseases.

Authors:  Ziyang Xu; Michelle Ho; Devivasha Bordoloi; Sagar Kudchodkar; Makan Khoshnejad; Leila Giron; Faraz Zaidi; Moonsup Jeong; Christine C Roberts; Young K Park; Joel Maslow; Mohamed Abdel-Mohsen; Kar Muthumani
Journal:  Methods Mol Biol       Date:  2022

6.  Neutrophils Are Required During Immunization With the Pneumococcal Conjugate Vaccine for Protective Antibody Responses and Host Defense Against Infection.

Authors:  Essi Y I Tchalla; Manmeet Bhalla; Elizabeth A Wohlfert; Elsa N Bou Ghanem
Journal:  J Infect Dis       Date:  2020-09-14       Impact factor: 5.226

7.  Glycoconjugates: What It Would Take To Master These Well-Known yet Little-Understood Immunogens for Vaccine Development.

Authors:  Fikri Avci; Francesco Berti; Peter Dull; John Hennessey; Viliam Pavliak; A Krishna Prasad; Willie Vann; Michael Wacker; Olivier Marcq
Journal:  mSphere       Date:  2019-09-25       Impact factor: 4.389

8.  Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem.

Authors:  Wenbo Jiang; Emily H Pilkington; Hannah G Kelly; Hyon-Xhi Tan; Jennifer A Juno; Adam K Wheatley; Stephen J Kent
Journal:  PLoS One       Date:  2020-11-02       Impact factor: 3.240

9.  Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine.

Authors:  Francesca Micoli; Stefania P Bjarnarson; Melissa Arcuri; Audur Anna Aradottir Pind; Gudbjorg J Magnusdottir; Francesca Necchi; Roberta Di Benedetto; Martina Carducci; Fabiola Schiavo; Carlo Giannelli; Ivan Pisoni; Laura B Martin; Giuseppe Del Giudice; Calman A MacLennan; Rino Rappuoli; Ingileif Jonsdottir; Allan Saul
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

10.  A Novel High-Potency Tetanus Vaccine.

Authors:  Amanda Przedpelski; William H Tepp; Sabine Pellett; Eric A Johnson; Joseph T Barbieri
Journal:  mBio       Date:  2020-08-11       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.